REAILITE BLOGS
First Artificial Intelligence Generated Drug Enters Clinical Trial
Artificial intelligence (A.I.) has taken the world by storm recently. Hundreds of news stories have been written in the past week about projects that have used A.I.. A recent opinion piece dissected the effects of A.I. on integrity in academia. A sports journal compiled a list of the top ten basketball players of all time using A.I.. Another media outlet has turned to the technology to provide commentary during their broadcast of Wimbledon. But on Thursday, June 29, the first drug to ever be fully generated by artificial intelligence entered clinical trials with human patients.
Organs-on-chips to Possibly Replace Animal Testing
Animal testing has long been necessary for a drug to gain approval from the FDA. However, in recent years, the method has raised concerns. Animal models, while similar to humans, aren’t similar enough to serve as an accurate test for more complex diseases like neurological diseases. In result, an emerging technology called organs-on-chips (OOCs) provides a new method that could revolutionize the way drugs are tested.
Battle of Bacteria - Fighting Antibiotic Resistance
Penicillin is arguably one of the greatest human inventions. Prior to its discovery in 1928, ear infections and strep throat were considered fatal. We no longer consider an irritated ear or a scratchy throat life-threatening, much in part to our ability to fight bacterial illnesses with antibiotics. But just as humans have adapted to the threat of bacteria, bacteria have also adapted to the threat of antibiotics. In fact, Bacteria have evolved to resist the effects of antibiotics.